This article is about an executive order signed by President Joe Biden. The order aims to improve the capacity of the US healthcare system to address COVID-19, accelerate the development of therapies for the disease, and improve access to quality and affordable healthcare for all Americans. The order includes various actions such as supporting clinical trials, providing surge assistance to healthcare facilities, reviewing the needs of federal facilities, issuing recommendations to increase healthcare workforce capacity, expanding access to programs for patients recovering from COVID-19, establishing targets for the production and distribution of treatments, identifying barriers to the use of existing treatments, evaluating and promoting access to treatments for the uninsured, and evaluating insurance coverage for COVID-19 treatments. The order is subject to applicable law and availability of appropriations and does not create any enforceable rights or benefits against the United States or its entities.